Factors associated with trial recruitment, preferences, and treatments received were elucidated in a comprehensive cohort study.

Factors associated with trial recruitment, preferences, and treatments received were elucidated in a comprehensive cohort study.

<p><strong>Objectives:</strong> Recruitment to pragmatic trials is often difficult, and little is known about factors associated with key participation and treatment decisions. These were explored in the Prostate cancer testing and Treatment (ProtecT) study.</p> <...

Detaylı Bibliyografya
Asıl Yazarlar:	Donovan, JL, Opmeer, B, Young, GJ, Mills, N, Martin, RM, Lane, JA, Metcalfe, C, Peters, TJ, Davis, M, Turner, EL, Walsh, E, Neal, DE, Hamdy, FC, ProtecT Study Group
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	Elsevier 2019

Benzer Materyaller

A prospective cohort and extended comprehensive-cohort design provided insights about the generalizability of a pragmatic trial: the ProtecT prostate cancer trial
Yazar:: Donovan, JL, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Prostate Testing for Cancer and Treatment (ProtecT) feasibility study
Yazar:: J. Donovan, ve diğerleri
Baskı/Yayın Bilgisi: (2003-01-01)

Modelling the lifetime cost-effectiveness of radical prostatectomy, radiotherapy and active monitoring for men with clinically localised prostate cancer from median 10-year outcomes in the ProtecT randomised trial
Yazar:: S. Sanghera, ve diğerleri
Baskı/Yayın Bilgisi: (2020-10-01)

Prostate-specific antigen (PSA) testing of men in UK general practice: a 10-year longitudinal cohort study
Yazar:: Young, GJ, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Addressing patient treatment preferences at trial recruitment.
Yazar:: Mills, N, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Exploring treatment preferences facilitated recruitment to randomized controlled trials
Yazar:: Mills, N, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Exploring treatment preferences facilitated recruitment to randomized controlled trials.
Yazar:: Mills, N, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Patient-reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and quality of life.
Yazar:: Lane, A, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Factors distinguishing general practitioners who more readily participated in a large randomized trial were identified.
Yazar:: Down, L, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Addressing patient treatment preferences at trial recruitment
Yazar:: Mills Nicola, ve diğerleri
Baskı/Yayın Bilgisi: (2011-12-01)

Who can best recruit to randomized trials? Randomized trial comparing surgeons and nurses recruiting patients to a trial of treatments for localized prostate cancer (the ProtecT study).
Yazar:: Donovan, J, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Systematic review and meta-analysis of the associations between body mass index, prostate cancer, advanced prostate cancer, and prostate-specific antigen
Yazar:: Harrison, S, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

The QuinteT Recruitment Intervention supported five randomized trials to recruit to target: a mixed-methods evaluation
Yazar:: Rooshenas, L, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

A comparison of socio-demographic and psychological factors between patients consenting to randomisation and those selecting treatment (the ProtecT study).
Yazar:: Mills, N, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Association of diabetes mellitus with prostate cancer: nested case-control study (Prostate testing for cancer and treatment study).
Yazar:: Turner, E, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Radiotherapy for prostate cancer: is it 'what you do' or 'the way that you do it'? A UK perspective on technique and quality assurance.
Yazar:: Mason, MD, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Low risk research using routinely collected identifiable health information without informed consent: encounters with the Patient Information Advisory Group.
Yazar:: Metcalfe, C, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Informed consent in randomised controlled trials: development and preliminary evaluation of a measure of participatory and informed consent (PIC)
Yazar:: Wade, J, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Characteristics of men responding to an invitation to undergo testing for prostate cancer as part of a randomised trial.
Yazar:: Walsh, E, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Experiences and decision processes during PSA testing and prostate biopsy: A qualitative study
Yazar:: Avery, K, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Seasonal variation in prostate-specific antigen levels: A large cross-sectional study of men in the UK
Yazar:: Down, L, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Prostate-specific antigen testing and prostate biopsy: are self-reported lower urinary tract symptoms and health-related quality of life associated with the decision to undergo these investigations?
Yazar:: Avery, K, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Do the risk factors of age, family history of prostate cancer or a higher prostate specific antigen level raise anxiety at prostate biopsy?
Yazar:: Macefield, R, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Seasonal variation in prostate-specific antigen levels: a large cross-sectional study of men in the UK.
Yazar:: Down, L, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Latest results from the UK trials evaluating prostate cancer screening and treatment: the CAP and ProtecT studies.
Yazar:: Lane, J, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer
Yazar:: Hamdy, FC, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

ProDiet: A phase II randomized placebo-controlled trial of green tea catechins and lycopene in men at increased risk of prostate cancer
Yazar:: Lane, JA, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

ASSOCIATIONS OF SEXUAL DYSFUNCTION WITH LOCALIZED AND ADVANCED PROSTATE CANCER: A CASE-CONTROL STUDY NESTED WITHIN THE UK POPULATION-BASED PROTECT (PROSTATE TESTING FOR CANCER AND TREATMENT) STUDY
Yazar:: Collin, S, ve diğerleri
Baskı/Yayın Bilgisi: (2009)

Effect of a low-intensity PSA-based screening intervention on prostate cancer mortality: The CAP randomized clinical trial
Yazar:: Martin, RM, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer
Yazar:: Donovan, J, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Ethics of clinical trials from bayesian perspective: randomisation to clinical trials may solve dilemma of treatment choice in prostate cancer.
Yazar:: Hamdy, F, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

The protect trial - Evaluating the effectiveness of treatments for clinically localised prostate cancer and associated molecular and genetic epidemiology studies
Yazar:: Lane, J, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Understanding and improving recruitment to randomised controlled trials: Qualitative research approaches.
Yazar:: Elliott, D, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Ten-year mortality, disease progression, and treatment-related side effects in men with localised prostate cancer from the protecT randomised controlled trial according to treatment received
Yazar:: Neal, D, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Elucidation of Clathrin-Mediated Endocytosis in Tetrahymena Reveals an Evolutionarily Convergent Recruitment of Dynamin.
Baskı/Yayın Bilgisi: (2005-11-01)

Elucidation of clathrin-mediated endocytosis in tetrahymena reveals an evolutionarily convergent recruitment of dynamin.
Yazar:: Nels C Elde, ve diğerleri
Baskı/Yayın Bilgisi: (2005-11-01)

A review of reporting of participant recruitment and retention in RCTs in six major journals
Yazar:: Tomlin Zelda, ve diğerleri
Baskı/Yayın Bilgisi: (2009-07-01)

Longitudinal prostate-specific antigen reference ranges: Choosing the underlying model of age-related changes
Yazar:: Simpkin, A, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Contribution of a single repeat PSA test to prostate cancer risk assessment: experience from the ProtecT study.
Yazar:: Rosario, D, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

Associations of sexual dysfunction symptoms with PSA-detected localised and advanced prostate cancer: a case-control study nested within the UK population-based ProtecT (Prostate testing for cancer and Treatment) study.
Yazar:: Collin, S, ve diğerleri
Baskı/Yayın Bilgisi: (2009)